21 October 2019AmericasLudmila Kawakami and Ana Paula Couto
Medicinal cannabis: what next for Brazil?
The medicinal use of Cannabis has been reported since 2,900 BC, originally in China, and was introduced into western medicine around 1840 (Grieco, M. Protection and Regulation of the Legal Use of Cannabis—Impact and Opportunities in relation to IP. In: XXXIX International Congress of Intellectual Property of the Brazilian Intellectual Property Association (ABPI). Rio de Janeiro, 2019).
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
26 February 2026 As the US Supreme Court prepares to hear arguments in the Hikma and Amarin dispute, the case has drawn a broad coalition of industry support—including the US government and a co-author of the Hatch-Waxman Act itself.
26 February 2026 In a decision with implications for biotechnology licensing and pharmaceutical manufacturing, the Ninth Circuit has rejected a ‘sweeping’ royalty trigger from a lower court.
25 February 2026 The Danish company is contending with fierce competition, a clinical trial setback and a UK boost to its main rival, while making new moves to enforce its weight-loss-drug IP.